Group One Trading’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-100
Closed -$10.4K 7711
2023
Q1
$10.4K Sell
100
-67,900
-100% -$6.57M ﹤0.01% 5910
2022
Q4
$6.03M Buy
68,000
+3,300
+5% +$274K 0.01% 1032
2022
Q3
$5.19M Buy
+64,700
New +$6.1M 0.01% 1139
2022
Q2
Sell
-1,900
Closed -$282K 7902
2022
Q1
$282K Buy
+1,900
New +$265K ﹤0.01% 4434
2021
Q3
Sell
-57,000
Closed -$7.83M 8227
2021
Q2
$7.83M Hold
57,000
0.01% 1285
2021
Q1
$7.44M Hold
57,000
0.01% 1182
2020
Q4
$6.38M Buy
+57,000
New +$5.4M 0.01% 1113
2019
Q4
Sell
-5,500
Closed -$529K 5165
2019
Q3
$529K Buy
+5,500
New +$516K ﹤0.01% 2289
2016
Q3
Sell
-4,900
Closed -$234K 4577
2016
Q2
$234K Buy
4,900
+300
+7% +$12.7K ﹤0.01% 2294
2016
Q1
$193K Sell
4,600
-5,200
-53% -$204K ﹤0.01% 2338
2015
Q4
$432K Buy
+9,800
New +$425K 0.01% 1932

Other funds holding CNMD

Group One Trading's CNMD Position: Q1 2025 in Review

Group One Trading sold out of CONMED (CNMD) in Q1 2025, closing a stake of 103 shares — an estimated $7.05K sold.

Group One Trading first reported a position in CNMD in Q2 2015 and held it in 12 quarters. The position peaked at $2.4M in Q4 2020. 280 funds tracked by Wall St. Rank hold CNMD as of Q1 2025.

  • Group One Trading reported no remaining CONMED position as of Q1 2025 after selling out during the quarter.
  • Group One Trading sold 103 CONMED shares in Q1 2025, an estimated $7.05K.
  • Group One Trading first reported a position in CONMED in Q2 2015 and held it in 12 quarters.
  • Group One Trading's CONMED position peaked at $2.4M in Q4 2020.
  • 280 funds tracked by Wall St. Rank held CONMED as of Q1 2025.

Based on Group One Trading's 13F filing for Q1 2025, filed 14 May 2025.